These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25972191)

  • 1. General considerations in ocular toxicity risk assessment from the toxicologists' viewpoints.
    Onodera H; Sasaki S; Otake S; Tomohiro M; Shibuya K; Nomura M
    J Toxicol Sci; 2015 Jun; 40(3):295-307. PubMed ID: 25972191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular toxicity assessment from systemically administered xenobiotics: considerations in drug development.
    Brock WJ; Somps CJ; Torti V; Render JA; Jamison J; Rivera MI
    Int J Toxicol; 2013; 32(3):171-88. PubMed ID: 23616147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early safety assessment of human oculotoxic drugs using the zebrafish visualmotor response.
    Deeti S; O'Farrell S; Kennedy BN
    J Pharmacol Toxicol Methods; 2014; 69(1):1-8. PubMed ID: 24091134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and Electroretinographic Characterization of the Minipig Eye in the Context of Drug Safety Investigations.
    Negro Silva LF; Li C; de Seadi Pereira PJB; Tan W; Dubuc-Mageau M; Sanfacon A; Forster R; Tavcar R; Makin A; Authier S
    Int J Toxicol; 2019; 38(5):415-422. PubMed ID: 31470746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety evaluation of ocular drug delivery formulations: techniques and practical considerations.
    Short BG
    Toxicol Pathol; 2008 Jan; 36(1):49-62. PubMed ID: 18337221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target organ profiles in toxicity studies supporting human dosing: an assessment of recovery and chronic dosing.
    Horner S; Robinson S; Lees D; Callander R; Roberts R
    Regul Toxicol Pharmacol; 2014 Oct; 70(1):270-85. PubMed ID: 25020275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular Toxicity of Tyrosine Kinase Inhibitors.
    Davis ME
    Oncol Nurs Forum; 2016 Mar; 43(2):235-43. PubMed ID: 26906134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonclinical safety evaluation of muraglitazar, a novel PPARalpha/gamma agonist.
    Waites CR; Dominick MA; Sanderson TP; Schilling BE
    Toxicol Sci; 2007 Nov; 100(1):248-58. PubMed ID: 17675651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current practices for monitoring ocular toxicity related to hydroxychloroquine (Plaquenil) therapy.
    Mazzuca SA; Yung R; Brandt KD; Yee RD; Katz BP
    J Rheumatol; 1994 Jan; 21(1):59-63. PubMed ID: 8151589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous ophthalmic lesions in young Swiss mice.
    Hubert MF; Gerin G; Durand-Cavagna G
    Lab Anim Sci; 1999 Jun; 49(3):232-40. PubMed ID: 10403436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular complications of systemic medications.
    Blomquist PH
    Am J Med Sci; 2011 Jul; 342(1):62-9. PubMed ID: 21139494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylated Biopharmaceuticals: Current Experience and Considerations for Nonclinical Development.
    Ivens IA; Achanzar W; Baumann A; Brändli-Baiocco A; Cavagnaro J; Dempster M; Depelchin BO; Rovira AR; Dill-Morton L; Lane JH; Reipert BM; Salcedo T; Schweighardt B; Tsuruda LS; Turecek PL; Sims J
    Toxicol Pathol; 2015 Oct; 43(7):959-83. PubMed ID: 26239651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular toxicity and cancer chemotherapy. A review.
    al-Tweigeri T; Nabholtz JM; Mackey JR
    Cancer; 1996 Oct; 78(7):1359-73. PubMed ID: 8839540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The accuracy of extended histopathology to detect immunotoxic chemicals.
    Germolec DR; Kashon M; Nyska A; Kuper CF; Portier C; Kommineni C; Johnson KA; Luster MI
    Toxicol Sci; 2004 Dec; 82(2):504-14. PubMed ID: 15342959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.